Related Experiment Video
Updated: Mar 15, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
A patient with MEN1 typical features and MEN2-like features.
Diala El-Maouche1, James Welch2, Sunita K Agarwal2
1Division of Endocrinology, Diabetes & Metabolism, Miller School of Medicine, University of Miami, Miami, FL, USA; National Institute of Dental & Craniofacial Research (NIDCR), NIH, Bethesda, MD, USA.
This report details a rare patient exhibiting features of both Multiple Endocrine Neoplasia type 1 (MEN1) and type 2 (MEN2). The findings suggest potential links between the molecular pathways of MEN1 and MEN2.
Area of Science:
- Endocrinology
- Genetics
- Oncology
Background:
- Multiple Endocrine Neoplasia (MEN) type 1 (MEN1) and type 2 (MEN2) are distinct genetic disorders.
- Co-occurrence of MEN1 and MEN2 in a single patient is exceptionally rare.
Purpose of the Study:
- To report the first case of a patient with typical MEN1 clinical findings and a MEN2-like phenotype.
- To investigate the genetic basis of this rare combined presentation.
Main Methods:
- Clinical evaluation for MEN1 and MEN2 features.
- Germline DNA analysis for mutations in MEN1, CDKN1B (p27), and RET genes.
- Analysis of RET polymorphisms.
Main Results:
- The patient presented with MEN1 features, pheochromocytoma, and thickened corneal nerves.
- A germline 1132delG frameshift mutation in the MEN1 gene was identified.
- No pathogenic RET mutations were found, but RET polymorphisms Gly691Ser and Arg982Cys were present.
Conclusions:
- This case represents a unique combination of MEN1 and a MEN2-like phenotype without pathogenic RET mutations.
- Potential explanations include novel phenotype-genotype associations or modifying effects of RET variants.
- The findings may indicate shared molecular pathways between MEN1 and MEN2.
Related Concept Videos
Abnormal Proliferation
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

